Further work is required to define the role of circulating IgM in the specific clearance of nucleated cells and erythrocytes with severely compromised cell membranes in vivo in conditions such as ischemic injury, sepsis and thrombotic microangiopathies. The gene discussed is CD40LG; the disease is Sepsis.